Madrigal Pharmaceuticals, Inc. (MDGL)
533.41
-7.67
(-1.42%)
USD |
NASDAQ |
Sep 08, 15:59
533.41
0.00 (0.00%)
After-Hours: 19:57
Madrigal Pharmaceuticals Max Drawdown (5Y) : 82.20% for Aug. 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| August 31, 2026 | 82.20% |
| July 31, 2026 | 82.20% |
| June 30, 2026 | 82.20% |
| May 31, 2026 | 82.20% |
| April 30, 2026 | 82.20% |
| March 31, 2026 | 82.20% |
| February 28, 2026 | 82.20% |
| January 31, 2026 | 82.20% |
| December 31, 2025 | 82.20% |
| November 30, 2025 | 82.20% |
| October 31, 2025 | 82.20% |
| September 30, 2025 | 82.20% |
| August 31, 2025 | 82.20% |
| July 31, 2025 | 82.20% |
| June 30, 2025 | 82.20% |
| May 31, 2025 | 82.20% |
| April 30, 2025 | 82.20% |
| March 31, 2025 | 82.20% |
| February 28, 2025 | 82.20% |
| January 31, 2025 | 82.20% |
| December 31, 2024 | 82.20% |
| November 30, 2024 | 82.20% |
| October 31, 2024 | 82.20% |
| September 30, 2024 | 82.20% |
| August 31, 2024 | 82.20% |
| Date | Value |
|---|---|
| July 31, 2024 | 82.20% |
| June 30, 2024 | 82.20% |
| May 31, 2024 | 82.20% |
| April 30, 2024 | 82.20% |
| March 31, 2024 | 82.20% |
| February 29, 2024 | 82.20% |
| January 31, 2024 | 82.20% |
| December 31, 2023 | 82.20% |
| November 30, 2023 | 82.20% |
| October 31, 2023 | 82.20% |
| September 30, 2023 | 82.20% |
| August 31, 2023 | 82.20% |
| July 31, 2023 | 82.20% |
| June 30, 2023 | 82.20% |
| May 31, 2023 | 82.20% |
| April 30, 2023 | 82.20% |
| March 31, 2023 | 82.20% |
| February 28, 2023 | 82.20% |
| January 31, 2023 | 82.20% |
| December 31, 2022 | 82.20% |
| November 30, 2022 | 88.70% |
| October 31, 2022 | 90.40% |
| September 30, 2022 | 90.40% |
| August 31, 2022 | 95.82% |
| July 31, 2022 | 96.22% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 58.17% |
| Exelixis, Inc. | 53.09% |
| United Therapeutics Corp. | 33.00% |
| Karyopharm Therapeutics, Inc. | 99.16% |
| ACADIA Pharmaceuticals, Inc. | 77.18% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 50.66 |
| Beta (5Y) | -0.9768 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 149.1% |
| Historical Sharpe Ratio (5Y) | 0.2803 |
| Historical Sortino (5Y) | 1.655 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 20.60% |